Indian share markets closed lower today (14 July 2026)

Indian share markets closed lower today (14 July 2026) as the Sensex fell 561 points to 77,054 and Nifty slipped below 24,100, pressured by surging crude oil prices and weak global cues amid escalating US–Iran tensions. Pharma and select midcaps outperformed, while banks, autos, and IT stocks dragged indices down. 📉 India Market Highlights (14 July 2026) Sensex: Closed at 77,054.94, down 561 points (-0.72%) Nifty 50: Settled at 24,052.05, down 0.66% Sectoral performance: Top gainers: Nuvoco Vistas (+7.9%), Biocon (+6.4%),

(+6.3%), (+5%) Weak sectors: Nifty Bank (-1.15%), Nifty Auto (-1.61%), Nifty IT (-1%) Currency: Rupee weakened past ₹96/USD, lowest in a month Market breadth: Declines outpaced advances, showing broad weakness 🌍 Global Market Context Oil prices: Brent crude climbed past $85/barrel, its biggest two‑day gain since 2020, after the US reinstated a blockade on Iranian shipping through the Strait of Hormuz. This raised inflation and supply disruption fears. US markets (13 July close): Dow Jones fell 138 points (-0.26%) S&P 500 dropped 0.79% Nasdaq plunged 1.55%, led by tech weakness Asian markets: Mixed performance — Japan’s Nikkei down 0.84%, South Korea’s Kospi down 3.1%, while Shanghai Composite rose 1.36%. Europe: STOXX 600 ended flat; Germany’s DAX and France’s CAC 40 posted modest gains, while UK’s FTSE 100 was supported by energy stocks. ⚠️ Key Drivers Today Geopolitical tensions: US–Iran conflict escalated with naval blockade and transit fees, spiking crude oil prices. Inflation concerns: Rising oil costs and weak rupee add pressure on India’s import bill and inflation outlook. IT sector drag: Despite recent strength, Infosys, HCLTech, and others saw profit‑taking. Pharma resilience: Biocon surged over 6% after Mylan’s stake exit, boosting sentiment in the sector.